Hepatitis b drug trial halted midway
NCT ID NCT02577029
First seen Jan 18, 2026 · Last updated May 14, 2026 · Updated 25 times
Summary
This study tested an experimental drug called ARC-520 in 79 adults with chronic hepatitis B. Some participants received ARC-520 alone, while others got it with standard treatments like entecavir or tenofovir. The goal was to see if ARC-520 could lower hepatitis B surface antigen levels. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site 1
Westmead, New South Wales, 2145, Australia
-
Research Site 10
Sofia, 1431, Bulgaria
-
Research Site 11
Sofia, 1463, Bulgaria
-
Research Site 12
Varna, 9020, Bulgaria
-
Research Site 13
Pleven, 5800, Bulgaria
-
Research Site 14
Hong Kong, China
-
Research Site 15
Seoul, 6273, South Korea
-
Research Site 16
Daegu, 41944, South Korea
-
Research Site 17
Busan, 49241, South Korea
-
Research Site 18
Seoul, 3080, South Korea
-
Research Site 19
Busan, South Korea
-
Research Site 2
Parkville, Victoria, 3052, Australia
-
Research Site 20
Seoul, South Korea
-
Research Site 21
Auckland, 1010, New Zealand
-
Research Site 23
Papatoetoe, Aukland, 2025, New Zealand
-
Research Site 24
Dunedin, Otago-Southland, New Zealand
-
Research Site 25
Chisinau, MD-2004, Moldova
-
Research Site 26
Changhua, 500, Taiwan
-
Research Site 27
Douliu, Yunlin County, 640, Taiwan
-
Research Site 28
Kaohsiung City, 807, Taiwan
-
Research Site 29
Bangkok, 10330, Thailand
-
Research Site 3
Camperdown, New South Wales, 2050, Australia
-
Research Site 30
Bangkok, 10400, Thailand
-
Research Site 31
Khon Kaen, 40002, Thailand
-
Research Site 32
Bangkok, 10400, Thailand
-
Research Site 33
Chiang Mai, 50200, Thailand
-
Research Site 34
Pathum Thani, 12120, Thailand
-
Research Site 4
Fitzroy, Victoria, 3065, Australia
-
Research Site 5
Darlinghurst, New South Wales, 2010, Australia
-
Research Site 6
Clayton, Victoria, 3168, Australia
-
Research Site 7
Nedlands, Washington, 6009, Australia
-
Research Site 8
Concord, New South Wales, 2139, Australia
-
Research Site 9
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.